Week in review: February 20, 2018
Week in review: February 20, 2018
Subscribe to get weekly updated delivered directly to your inbox!
Consultations, feedback, and events
- CYCLING:
- #CycleON strategy Action Plan 2.0, comments due March 7
- Cambridge Cycling Focus Group looking for members, due Feb 27
- Cycle tourism questionnaire
- TRANSIT: 2018 network public information centres, March 21, 22, April 4, 5, 10, 11
- UNIVERSITY AVE: Streetscape public consultation
- MHBPNA PRESENTS: Sustainable streets April 6
- LAND USE: Proposed methodology for land needs assessment for the Greater Golden Horseshoe, comments due Feb 28
- EMISSIONS: Guidelines on community emissions planning, comments due March 4
- GREENBELT: Growing the Greenbelt in the outer ring Feb 22, comments due March 7
- TAXES: Property tax policies, due March 2
On foot
- Uptown Waterloo to get rainbow crosswalk (Waterloo Chronicle)
- We should be building bridges not walls (Kitchener Post)
In transit
- Transit network changes public consultations announced (GRT)
- LRT vehicle testing moves deeper into Kitchener (CTV)
- Spending on King St. up since streetcar pilot began (The Star)
By bike
- Don’t let anyone tell you we don’t know how to increase biking in a city (People for bikes)
- How America’s bike helmet fixation upholds a culture of “unfettered automobility” (Streetsblog)
Vision Zero
- 5 things you can do right now to #slowthecars in your town (Strong Towns)
The shape of our cities
- Guelph, Waterloo Region among Canada’s fastest-growing areas (CTV)
- Renting will be more affordable in Cambridge, if city changes secondary suite process (CBC)
- Ontario’s failed downtown malls (Sean Marshall)
- The perilous politics of parking (The Economist)
- A small zoning change could have big implications for Lexington (Strong Towns)
The road ahead
- Waterloo Taxi’s Lokal app hopes to take on ridesharing (Waterloo Chronicle)
- All-female ridesharing service brings peace of mind for women (Kitchener Post)
- Is microtransit an actual idea? (Human Transit)
- Uber quarterly sales rose 61% to $2 billion amid heavy loss (Bloomberg)
This post is licensed under CC BY 4.0 by the author.